On Wednesday, September 20, Buchanan will be hosting its 2nd Annual Buchanan Life Sciences Summit in Philadelphia! The panelists will cover a range of vital topics including the impact of drug pricing, regulatory and enforcement trends, the optimization and maximization of clinical trials, the protection of trade secrets, the management of life sciences partnerships and more. We will also hear directly from the General Counsel of life sciences companies who will candidly share their experiences and lessons learned from being in-house.
- Breakfast Keynote - The Bottom Line | Impacts of Drug Pricing Legislation and Beyond
- Michael Strazzella | Buchanan
- Keynote Presentation - Regulatory and Legal Enforcement in Life Sciences | Trends to Watch
- George Karavetsos, Allison Borgatti, Jason Bologna, Mark Kasten and Megan Scheib (moderator) | Buchanan
- Prioritizing the Priorities | Lessons Learned as a Life Sciences Company's General Counsel
- Kimberly Banks MacKay | West Pharmaceutical Services, Inc.
- Linda Pissott Reig | Buchanan
- Jennifer Sanfilippo | Melinta Therapeutics
- Risky Business | Strategies for Managing Essential Life Sciences Partnerships
- Rob Holland | Sandoz Inc.
- Jason Parish and Tina Hu-Rodgers | Buchanan
- Optimizing Clinical Trials | Maximizing Value from Concept to Implementation
- Barbara Binzak Blumenfeld, Ph.D., Michelle Garvey Brennfleck, Jennifer Minter and Duane Stewart | Buchanan
- Lauren Misztal | Clario
- Trade Secrets & Life Sciences | Protecting Value from Walking Out the Door
- Marjorie Adams | Ferring Pharmaceuticals
- Jonathan Janow, Jason Murtagh and James Wilcox | Buchanan
Speakers:
SVP, General Counsel and Corporate Secretary
Director, Associate General Counsel and BD&L, Strategy and Portfolio
Head of Employment & Litigation/Associate General Counsel
SVP, General Counsel and Corporate Secretary
Director, Associate General Counsel and BD&L, Strategy and Portfolio
Head of Employment & Litigation/Associate General Counsel